Authors
Latest:
Ecolab Continues Mission to Protect What's Vital With Deep Investment in Life SciencesEcolab is looking to the future with new opportunities to partner with Pharma for critical solutions to support drug development and manufacturing.
Latest:
Trends in Single-Use BiomanufacturingSingle-use technologies have gained broad acceptance in biomanufacturing within the past few years, supporting flexible and cost-effective clinical production.
Latest:
Outsourced Manufacturing OperationsManufacturers are facing ever-increasing competition while end users are expecting better value and efficacy. The authors discuss these challenges and offer practical solutions.
Latest:
What's on the Box?Counterfeiting continues to be a huge challenge affecting both branded and generic products, which, although a worldwide issue, is especially prominent in developing countries.
Latest:
Challenges In The Changing Outsourcing LandscapeOriol Prat, Marketing Manager, and Marga Viñes Senior Product Manager, from Grifols give us a quick rundown of how business is changing and what challenges the company faces.
Latest:
Past, Present and Future of Softgel TechnologiesSoftgels are now being recognised as one of the preferred dosage forms for the treatment of pain, eye conditions, cough and cold, as well as allergy.
Latest:
Insourcing vs Outsourcing: Choosing the Right StrategyThe article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Latest:
The Use Of UHPLC In Post-Drug DevelopmentUHPLC offers increased performance compared with HPLC, including shorter analysis times and increased sensitivity.
Latest:
Perspectives in MicroRNA TherapeuticsThe authors provide further insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
Latest:
Quality by Design: A CMO's Perspective on Gaining Knowledge Faster and BetterTraditional project decision-making is compared with a QbD approach.
Latest:
Checklist for Computer Software ValidationNon-compliance issues show that users find dealing with computer systems challenging.
Latest:
Single-Use: Game-Changing Technology for the Biopharmaceutical IndustryThe success of new biopharmaceutical drugs also relies on innovative solutions such as single-use technologies that suppliers have to offer to the pharmaceutical industry.
Latest:
Improving R&D with API microdosingDirect dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department.
Latest:
Maturing Aseptic Technologies Create More Flexible FacilitiesInnovative therapeutic approaches beyond mAbs will require new methods for future facility construction.
Latest:
EU Market ChallengesAlthough the European market is approximately 50% smaller than the US in terms of landmass, the population of Europe is approximately 50% larger and this presents a huge market opportunity.
Latest:
Offering a Pharma View of Social MediaWhy social media presents unique challenges and opportunities for pharmaceutical companies.
Latest:
Technology and QbD Drive Pharma DevelopmentQuality by design, process analytical technology, and high throughput screening have helped drive progress in pharmaceutical development.
Latest:
Data Governance, Data Integrity, and Data Quality: What’s the Connection?Data governance, data integrity, and data quality are all widely used terms, but what do they actually mean and how are they connected?
Latest:
The Relationship Between Packaging And The PatientIn light of the challenges facing the pharma industry, such as changing patient demands and changing demographics, the relationship between the packaging, the consumer and the product is being completely reconsidered.
Latest:
Guest Viewpoint: A Case for an FDA Dean's ListQuality is a matter of culture more than metrics. In this opinion article, the author presents arguments for an FDA Dean's List as a means to nurture a quality culture within the industry.
Latest:
The Future of Downstream ProcessingThe author reviews the state of downstream processing and considers potential solutions, including the streamlining of full processes and borrowed technologies.
Latest:
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified CommunicationsIn Part 1 of this blog, Richard Freeman looked at some of the challenges faced by pharma firms today as a result of growing competition, regulation and globalization, and argued that more effective communication and collaboration was key to their continued success.
Latest:
Impurity Profiling Using Convergence Chromatography and Mass SpectrometryThe authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.
Latest:
Bridging the Gap from Molecule to DrugFormulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Latest:
QbD: Improving Pharmaceutical Development and Manufacturing Workflows to Deliver Better Patient OutcomesImplementing quality by design in product design and formulation and manufacturing workflows can help improve efficiency and shorten development times.
